[go: up one dir, main page]

PT1765370E - Parapoxvirus em associação com outros agentes antivirais para o tratamento de hiv/sida - Google Patents

Parapoxvirus em associação com outros agentes antivirais para o tratamento de hiv/sida Download PDF

Info

Publication number
PT1765370E
PT1765370E PT05764629T PT05764629T PT1765370E PT 1765370 E PT1765370 E PT 1765370E PT 05764629 T PT05764629 T PT 05764629T PT 05764629 T PT05764629 T PT 05764629T PT 1765370 E PT1765370 E PT 1765370E
Authority
PT
Portugal
Prior art keywords
parapoxviruses
combination
aids
treatment
antiviral agents
Prior art date
Application number
PT05764629T
Other languages
English (en)
Inventor
Daniela Paulsen
Helga Ruebsamen-Waigmann
Amar Kureishi
Gerhard Hunsmann
Christiane Stahl-Hennig
Andreas Meyerhans
Alexandra Schuetz
Olaf Weber
Original Assignee
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35115792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1765370(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg
Publication of PT1765370E publication Critical patent/PT1765370E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT05764629T 2004-07-13 2005-07-08 Parapoxvirus em associação com outros agentes antivirais para o tratamento de hiv/sida PT1765370E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04016414 2004-07-13

Publications (1)

Publication Number Publication Date
PT1765370E true PT1765370E (pt) 2009-09-23

Family

ID=35115792

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05764629T PT1765370E (pt) 2004-07-13 2005-07-08 Parapoxvirus em associação com outros agentes antivirais para o tratamento de hiv/sida

Country Status (13)

Country Link
US (1) US8343478B2 (pt)
EP (1) EP1765370B1 (pt)
JP (1) JP4897677B2 (pt)
CN (2) CN1984666A (pt)
AT (1) ATE442155T1 (pt)
BR (1) BRPI0513321B1 (pt)
CA (1) CA2573204C (pt)
DE (1) DE602005016552D1 (pt)
DK (1) DK1765370T3 (pt)
ES (1) ES2330540T3 (pt)
PL (1) PL1765370T3 (pt)
PT (1) PT1765370E (pt)
WO (1) WO2006005529A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2849774A4 (en) * 2012-05-18 2015-11-25 Otago Innovation Ltd COMBINATION TREATMENTS AND COMPOSITIONS FOR WOUND HEALING
TW201919675A (zh) * 2017-09-07 2019-06-01 德商艾庫瑞斯公司 使用羊副痘疹病毒(Parapoxvirus ovis；PPVO)及至少一種額外抗病毒藥之經B型肝炎病毒(HBV)感染之個體之組合療法
CA3093093A1 (en) 2018-03-07 2019-09-12 Transgene Parapoxvirus vectors
SMT202200390T1 (it) * 2020-05-08 2022-11-18 Aicuris Gmbh & Co Kg Parapoxvirus per il condizionamento e il trattamento di infezioni da coronavirus
WO2023083950A1 (en) * 2021-11-10 2023-05-19 Aicuris Gmbh & Co. Kg Parapoxvirus for preparing for and treatment of respiratory virus infections in combination with immunomodulators
WO2023083943A1 (en) * 2021-11-10 2023-05-19 Aicuris Gmbh & Co. Kg Parapoxvirus for preparing for and treatment of respiratory virus infections in combination with antivirals
WO2024062098A1 (en) 2022-09-23 2024-03-28 Transgene Recombinant pseudocowpox virus encoding an interleukin-12

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JP2000507092A (ja) * 1996-02-28 2000-06-13 バイエル・アクチエンゲゼルシヤフト 外来ｄｎａを含むパラポックスウイルス、それらの製造及びワクチンにおけるそれらの使用
ATE203678T1 (de) * 1996-04-15 2001-08-15 Anton Prof Dr Med Vet Dr Mayr Verwendung von multipotenten paramunitätsinducern aus attenuierten, nicht-immunogenen pockenviren oder parapockenviren zur herstellung von arzneimitteln
DE19922407A1 (de) * 1999-05-14 2000-11-16 Bayer Ag Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus
EP1303286B1 (de) * 2000-07-11 2006-04-26 Bayer HealthCare AG Verwendung von stämmen des parapoxvirus ovis zur herstellung von antiviralen arzneimitteln und arzneimitteln gegen krebs

Also Published As

Publication number Publication date
US8343478B2 (en) 2013-01-01
EP1765370B1 (en) 2009-09-09
BRPI0513321B1 (pt) 2022-03-08
EP1765370A1 (en) 2007-03-28
JP2008505952A (ja) 2008-02-28
ATE442155T1 (de) 2009-09-15
BRPI0513321A (pt) 2008-05-06
US20100255032A1 (en) 2010-10-07
JP4897677B2 (ja) 2012-03-14
CA2573204C (en) 2011-09-20
CN1984666A (zh) 2007-06-20
CA2573204A1 (en) 2006-01-19
DE602005016552D1 (de) 2009-10-22
DK1765370T3 (da) 2009-11-02
WO2006005529A1 (en) 2006-01-19
PL1765370T3 (pl) 2010-02-26
ES2330540T3 (es) 2009-12-11
HK1097467A1 (en) 2007-06-29
CN103800382A (zh) 2014-05-21

Similar Documents

Publication Publication Date Title
TW200510343A (en) Substituted dihydroquinazolines
FR16C0028I2 (fr) Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
WO2021262826A3 (en) 1'-cyano nucleoside analogs and uses thereof
SG163517A1 (en) Antiviral compounds and methods
DE50102597D1 (de) Arzneimittel gegen virale erkrankungen
WO2005063734A3 (de) Substituierte thiophene
TW200630093A (en) Dose forms
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
AU2003291998A8 (en) Method and compositions for identifying anti-hiv therapeutic compounds
IL158558A0 (en) Antiviral compounds
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
TW200606177A (en) Glycoprotein VI antibodies and methods thereof
MXPA04006572A (es) Terapia de combinacion antivirica.
NO20052310L (no) Posisjonsisomerer av PEG IFN alfa 2A.
PT1765370E (pt) Parapoxvirus em associação com outros agentes antivirais para o tratamento de hiv/sida
TW200633718A (en) Treatment of hepatitis c in the asian population
WO2004065406A3 (en) Rantes-derived peptides with anti-hiv activity
CR20240365A (es) Compuestos antivirales y métodos de elaboración y uso de los mismos
SG170825A1 (en) Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
WO2006043153A3 (en) Use of zinc and copper chelators for the treatment of viral diseases
WO2004052905A3 (en) Antiviral nucleoside derivatives
TW200700411A (en) Heterocyclylamide-substituted imidazoles
WO2004043402A3 (en) Modified nucleosides as antiviral agents
WO2005058237A3 (en) Treatment of aids
WO2003051301A3 (en) USE OF dsRNAs IN STRATEGIC THERAPEUTIC INTERVENTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY